{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:36:36Z","timestamp":1790019396650,"version":"4.0.1"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Lung adenocarcinoma (LUAD) is the predominant subtype of non-small cell lung cancer (NSCLC), characterized by a complex tumor microenvironment (TME) where tumor-associated neutrophils (TANs) exert dual functions\u2014a concept now well-established in broader NSCLC and pan-cancer studies. Despite the advances in immune checkpoint inhibitors (ICIs), primary and acquired resistance remain major obstacles. This review comprehensively dissects the regulatory network of TANs in LUAD, including their recruitment via the CXCR1\/CXCR2 axis, polarization towards anti-tumorigenic N1 or pro-tumorigenic N2 phenotypes under the influence of TGF-\u03b2 and IFN-\u03b3, and the formation of neutrophil extracellular traps (NETs). We highlight the dual functions of TANs and NETs in both tumor promotion (immunosuppression, angiogenesis, metastasis) and tumor suppression (direct cytotoxicity, antigen presentation). Furthermore, we evaluate current therapeutic strategies targeting TANs, such as CXCR1\/2 inhibitors (SX-682, Navarixin), PAD4 inhibitors (Cl-amidine), NET-degrading enzymes (DNase I), TGF-\u03b2 inhibitors (Galunisertib), and myeloid modulators, with a focus on LUAD-specific preclinical and clinical evidence. Major challenges, including off-target toxicity, infection risk, and the lack of predictive biomarkers, are discussed. By bridging mechanistic insights with translational opportunities, this review provides a framework for developing neutrophil-targeted combination therapies to overcome immunotherapy resistance in LUAD.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1892405","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:35:24Z","timestamp":1784525724000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor-associated neutrophils in lung adenocarcinoma: from mechanisms to therapeutic targeting"],"prefix":"10.3389","volume":"17","author":[{"given":"Ruichen","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Clinical and Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Science","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2024.107956","article-title":"Lung cancer screening - Time for an update","volume":"196","author":"Marshall","year":"2024","journal-title":"Lung Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay9040","article-title":"Early detection of cancer","volume":"375","author":"Crosby","year":"2022","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"Leiter","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2016.02.003","article-title":"Classification and pathology of lung cancer","volume":"25","author":"Zheng","year":"2016","journal-title":"Surg Oncol Clin N Am"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: Impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-013110","article-title":"Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better","volume":"13","author":"van der Geest","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3694","article-title":"Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through singlecell transcriptomic analysis: Implications for distinct immunotherapy outcomes","volume":"26","author":"Fang","year":"2024","journal-title":"J Gene Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188762","article-title":"Tumor-associated neutrophils and neutrophil-targeted cancer therapies","volume":"1877","author":"Que","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00571-6","article-title":"Neutrophils in cancer: heterogeneous and multifaceted","volume":"22","author":"Hedrick","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \"N1\" versus \"N2\" TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.2139\/ssrn.4113512","article-title":"High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer","volume":"40","author":"Salcher","year":"2022","journal-title":"Cancer Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-02916-5","article-title":"Myeloid cell heterogeneity in lung cancer: implication for immunotherapy","volume":"70","author":"Sangaletti","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0222-4","article-title":"Tumour-associated neutrophils in patients with cancer","volume":"16","author":"Shaul","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00262-017-1976-0","article-title":"Phenotype and function of tumor-associated neutrophils and their subsets in early-stage human lung cancer","volume":"66","author":"Eruslanov","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201902467r","article-title":"Circulating neutrophil subsets in advanced lung cancer patients exhibit unique immune signature and relate to prognosis","volume":"34","author":"Shaul","year":"2020","journal-title":"FASEB J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.001","article-title":"NETworking with cancer: the bidirectional interplay between cancer and neutrophil extracellular traps","volume":"41","author":"Adrover","year":"2023","journal-title":"Cancer Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1152\/physrev.00062.2021","article-title":"Neutrophil extracellular traps in the pathology of cancer and other inflammatory diseases","volume":"103","author":"Herre","year":"2023","journal-title":"Physiol Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7150\/thno.111096","article-title":"Targeting neutrophil extracellular traps in cancer progression and metastasis","volume":"15","author":"Zhang","year":"2025","journal-title":"Theranostics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-20-760","article-title":"Emerging and multifaceted role of neutrophils in lung cancer","volume":"10","author":"Aloe","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1186\/s12967-025-07084-z","article-title":"Neutrophils in non-small cell lung cancer and immunotherapy with PD-1\/PD-L1 inhibitors","volume":"23","author":"Hu","year":"2025","journal-title":"J Transl Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13588","article-title":"Role of tumor associated neutrophils in lung cancer (Review)","volume":"25","author":"Zhou","year":"2022","journal-title":"Oncol Lett"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2025.108893","article-title":"Targeting myeloid cell immunometabolism to improve current non-small cell lung cancer therapies","volume":"273","author":"Runtsch","year":"2025","journal-title":"Pharmacol Ther"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.676399","article-title":"Targeting of the neutrophil as an adjunctive strategy in non-small cell lung cancer","volume":"12","author":"Anderson","year":"2021","journal-title":"Front Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2024.01.010","article-title":"Beyond binary: bridging neutrophil diversity to new therapeutic approaches in NSCLC","volume":"10","author":"Horvath","year":"2024","journal-title":"Trends Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052929","article-title":"Neutrophils at the crossroads: Unraveling the multifaceted role in the tumor microenvironment","volume":"25","author":"Awasthi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.105087","article-title":"Bidirectional role of neutrophils in lung cancer: Mechanisms and therapeutic implications","volume":"218","author":"Wang","year":"2026","journal-title":"Crit Rev Oncol Hematol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16142507","article-title":"The multifaceted role of neutrophils in NSCLC in the era of immune checkpoint inhibitors","volume":"16","author":"Miao","year":"2024","journal-title":"Cancers"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1155","article-title":"Multiplex immunofluorescence and single-cell transcriptomic profiling reveal the spatial cell interaction networks in the non-small cell lung cancer microenvironment","volume":"13","author":"Peng","year":"2023","journal-title":"Clin Transl Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1340","article-title":"Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil","volume":"13","author":"Peng","year":"2023","journal-title":"Clin Transl Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26456","article-title":"Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer","volume":"118","author":"Ilie","year":"2012","journal-title":"Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13235972","article-title":"Role of tumor-associated neutrophils in the molecular carcinogenesis of the lung","volume":"13","author":"Taucher","year":"2021","journal-title":"Cancers"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.05.082","article-title":"Neutrophils kill antibody-opsonized cancer cells by trogoptosis","volume":"23","author":"Matlung","year":"2018","journal-title":"Cell Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29945","article-title":"Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human","volume":"138","author":"Andzinski","year":"2016","journal-title":"Int J Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.devcel.2024.10.010","article-title":"A subset of neutrophils activates anti-tumor immunity and inhibits non-small-cell lung cancer progression","volume":"60","author":"Tang","year":"2025","journal-title":"Dev Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14381","article-title":"Neutrophils dominate the immune cell composition in non-small cell lung cancer","volume":"8","author":"Kargl","year":"2017","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1172\/jci153643","article-title":"Annexin A2\/TLR2\/MYD88 pathway induces arginase 1 expression in tumor-associated neutrophils","volume":"132","author":"Zhang","year":"2022","journal-title":"J Clin Invest"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.785222","article-title":"Neutrophil extracellular traps promote T cell exhaustion in the tumor microenvironment","volume":"12","author":"Kaltenmeier","year":"2021","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1118-2","article-title":"Fatty acid transport protein 2 reprograms neutrophils in cancer","volume":"569","author":"Veglia","year":"2019","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101380","article-title":"Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors","volume":"5","author":"Pettinella","year":"2024","journal-title":"Cell Rep Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2521396","article-title":"Uncovering common transcriptional features shared by mature peripheral blood PMN-MDSCs and tumor-infiltrating neutrophils in humans","volume":"14","author":"Lattanzi","year":"2025","journal-title":"Oncoimmunology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao4227","article-title":"Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice","volume":"361","author":"Albrengues","year":"2018","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01749","article-title":"The emerging role of neutrophil extracellular traps (NETs) in tumor progression and metastasis","volume":"11","author":"Masucci","year":"2020","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-416156","article-title":"Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity","volume":"120","author":"Sangaletti","year":"2012","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.69257","article-title":"Neutrophil extracellular traps arm DC vaccination against NPM-mutant myeloproliferation","volume":"11","author":"Tripodo","year":"2022","journal-title":"Elife"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00096-14","article-title":"NADPH oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis","volume":"82","author":"R\u00f6hm","year":"2014","journal-title":"Infect Immun"},{"key":"B50","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s12879-025-10785-x","article-title":"Anesthetic choice impacts mortality and bacterial clearance in a murine experimental pneumonia model","volume":"25","author":"Gage","year":"2025","journal-title":"BMC Infect Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1743841","article-title":"Mechanistic and functional characterization of NETs\/IL-17 as a therapeutic target in EMT and brain metastasis of lung adenocarcinoma","volume":"17","author":"Cai","year":"2026","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40164-022-00345-3","article-title":"The role of neutrophil extracellular traps in cancer progression, metastasis and therapy","volume":"11","author":"Chen","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70192","article-title":"Neutrophil extracellular traps promote growth of lung adenocarcinoma by mediating the stability of m6A-mediated SLC2A3 mRNA-induced ferroptosis resistance and CD8+ T cell inhibition","volume":"15","author":"Xu","year":"2025","journal-title":"Clin Transl Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-sitc2020.0755","article-title":"CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity","volume":"52","author":"Teijeira","year":"2020","journal-title":"Immunity"},{"key":"B55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13073-023-01164-9","article-title":"Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing","volume":"15","author":"Hu","year":"2023","journal-title":"Genome Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130850","article-title":"Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC","volume":"4","author":"Kargl","year":"2019","journal-title":"JCI Insight"},{"key":"B57","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12026-024-09563-9","article-title":"IGF2BP2 promotes lung adenocarcinoma progression by regulating LOX1 and tumor-associated neutrophils","volume":"73","author":"Qian","year":"2024","journal-title":"Immunol Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113787","article-title":"IL-37d enhances COP1-mediated C\/EBP\u03b2 degradation to suppress spontaneous neutrophil migration and tumor progression","volume":"43","author":"Guo","year":"2024","journal-title":"Cell Rep"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.116032","article-title":"Synergistic effects of neutrophil extracellular traps and NF-\u03baB on promoting tumor progression and immune evasion in lung adenocarcinoma","volume":"169","author":"Li","year":"2026","journal-title":"Int Immunopharmacol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2025.111147","article-title":"Neutrophil extracellular trap-related signature predicts the prognosis and immunotherapy outcome of lung adenocarcinoma","volume":"117","author":"Bai","year":"2025","journal-title":"Genomics"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.014.10153","article-title":"Liraglutide enhances immunotherapy in cancer","volume":"14","author":"Chen","year":"2024","journal-title":"FEBS Open Bio"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/s41467-023-37515-8","article-title":"Smad3 is essential for polarization of tumor associated neutrophils in non-small cell lung carcinoma","volume":"14","author":"Chung","year":"2023","journal-title":"Nat Commun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2023.0248","article-title":"Cancer-educated neutrophils promote lung cancer progression via PARP-1-ALOX5-mediated MMP-9 expression","volume":"21","author":"Han","year":"2024","journal-title":"Cancer Biol Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.09.925","article-title":"Interleukin-17A promotes lung tumor progression through neutrophil attraction to tumor sites and mediating resistance to PD-1 blockade","volume":"12","author":"Akbay","year":"2017","journal-title":"J Thorac Oncol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006896","article-title":"CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity","volume":"11","author":"Salehi-Rad","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58081069","article-title":"Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers for advanced non-small-cell lung cancer treated with immunotherapy: a systematic review and meta-analysis","volume":"58","author":"Platini","year":"2022","journal-title":"Med (Kaunas)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106677","article-title":"Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis","volume":"85","author":"Zhang","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000028617","article-title":"The relationship between NLR\/PLR\/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors","volume":"101","author":"Liu","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/biom13121803","article-title":"Neutrophil-to-lymphocyte ratio (NLR) in NSCLC, gastrointestinal, and other solid tumors: immunotherapy and beyond","volume":"13","author":"Mosca","year":"2023","journal-title":"Biomolecules"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003536","article-title":"Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer","volume":"9","author":"Alessi","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12360","article-title":"Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer","volume":"7","author":"Rakaee","year":"2016","journal-title":"Oncotarget"},{"key":"B72","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3390\/biom16030400","article-title":"The neutrophil\u2013NET axis in immune checkpoint inhibitor","volume":"16","author":"Xu","year":"2026","journal-title":"Biomolecules"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2279754","article-title":"A novel neutrophil extracellular traps-related lncRNA signature predicts prognosis in patients with early-stage lung adenocarcinoma","volume":"55","author":"Wang","year":"2023","journal-title":"Ann Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.867516","article-title":"Neutrophil extracellular traps (NETs) promote non-small cell lung cancer metastasis by suppressing lncRNA MIR503HG to activate the NF-\u03baB\/NLRP3 inflammasome pathway","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12081831","article-title":"Prognostic significance of plasma neutrophil extracellular trap levels in patients with non-small cell lung cancer treated with immune checkpoint inhibitors","volume":"12","author":"Horaguchi","year":"2024","journal-title":"Biomedicines"},{"key":"B76","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cell.2017.09.019","article-title":"Lactate metabolism in human lung tumors","volume":"171","author":"Faubert","year":"2017","journal-title":"Cell"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-20-2870","article-title":"GLUT1 expression in tumor-associated neutrophils promotes lung cancer growth and resistance to radiotherapy","volume":"81","author":"Ancey","year":"2021","journal-title":"Cancer Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0229-5","article-title":"Unique pattern of neutrophil migration and function during tumor progression","volume":"19","author":"Patel","year":"2018","journal-title":"Nat Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaf8943","article-title":"Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients","volume":"1","author":"Condamine","year":"2016","journal-title":"Sci Immunol"},{"key":"B80","article-title":"PPAR\u03b3 modulation in alveolar macrophages","volume-title":"Targeting Myeloid Cell Immunometabolism to Improve Current non-Small Cell Lung Cancer Therapies","author":"Runtsch","year":"2025"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1186\/2051-1426-3-s2-o18","article-title":"Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies","volume":"3","author":"Hossain","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24448","article-title":"IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclear in nonsmall cell lung cancer","volume":"125","author":"Rotondo","year":"2009","journal-title":"Int J Cancer"},{"key":"B83","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40425-019-0504-5","article-title":"Suppression of myeloid cell arginase activity leads to therapeutic response in a NSCLC mouse model by activating anti-tumor immunity","volume":"7","author":"Miret","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67484","article-title":"Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis","volume":"123","author":"Cools-Lartigue","year":"2013","journal-title":"J Clin Invest"},{"key":"B85","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1186\/s12885-025-13811-y","article-title":"Neutrophil-to-lymphocyte ratio-based prognostic score can predict outcomes in patients with advanced non-small cell lung cancer treated with immunotherapy plus chemotherapy","volume":"25","author":"Liao","year":"2025","journal-title":"BMC Cancer"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-02944-1","article-title":"Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinoma","volume":"70","author":"Fan","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.22541\/au.160666923.36388912\/v1","article-title":"Circulating CD15+ LOX-1+ PMN-MDSCs are a potential biomarker for the early diagnosis of non-small-cell lung cancer","volume":"75","author":"Tian","year":"2021","journal-title":"Int J Clin Pract"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1304529","article-title":"Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1892405\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:35:26Z","timestamp":1784525726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1892405\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":88,"alternative-id":["10.3389\/fimmu.2026.1892405"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1892405","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"article-number":"1892405"}}